Matthew Gline received $3.1M in total compensation as Chief Executive Officer of Roivant Sciences Ltd. in FY2025. The largest component was $725K in base salary. That’s up 319% from FY2023. Source: SEC DEF 14A.
In fiscal year 2025, Matthew Gline, Chief Executive Officer of Roivant Sciences Ltd. (ROIV), received total compensation of $3.1 million.
Matthew Gline's compensation breakdown includes: base salary of $725K, bonus of $2.4 million, and other compensation of $12K.
Compared to fiscal year 2023, Matthew Gline's total compensation increased 319% from $738K to $3.1 million.
Roivant Sciences Ltd.'s top 5 named executive officers received combined total compensation of $156.3 million in fiscal year 2025.
The named executive officers disclosed in Roivant Sciences Ltd.'s 2025 proxy statement are:Matthew Gline (Chief Executive Officer) with total compensation of $3.1 million, Frank Torti (President and Vant Chair) with total compensation of $123.3 million, Eric Venker (President and Immunovant CEO) with total compensation of $24.4 million, Richard Pulik (Chief Financial Officer) with total compensation of $4.2 million, and Mayukh Sukhatme (President and Chief Investment Officer) with total compensation of $1.3 million.
Matthew Gline, Chief Executive Officer of Roivant Sciences Ltd. (ROIV), received $3,096,190 in total compensation for FY2025, up 319.4% from the prior year. Base salary of $725,000 was the largest component. Figures come from Roivant Sciences Ltd.'s DEF 14A 0001140361-26-029955 filed 29 Jul 2026.
Source Filing
Executive Record
Matthew Gline
Chief Executive Officer
Reported Pay
$3.1MSummary compensation table total · FY2025
Read the board's pay decision against shareholder returns and current filing context.
Roivant Sciences Ltd. (ROIV) — Key Facts
Last updated Oct 12, 2026 · DEF 14A filed Jul 29, 2026
| CEO | Matthew Gline, Chief Executive Officer |
|---|---|
| Fiscal year | FY2025 |
| Total compensation | $3.1M |
| Base salary | $725K |
| Other compensation | $12K |
| Year-over-year change | +319% |
| Source | DEF 14A, 2026-07-29 |
Matthew Gline, the Chief Executive Officer of Roivant Sciences Ltd., received total compensation of $3,096,190 in fiscal year 2025. This includes base salary of $725,000. Figures come from Roivant Sciences Ltd.'s DEF 14A 0001140361-26-029955 filed 29 Jul 2026.
Matthew Gline's base salary at Roivant Sciences Ltd. is $725,000 per year as of fiscal year 2025. However, total compensation including stock awards, bonuses, and other benefits is $3,096,190. Figures come from Roivant Sciences Ltd.'s DEF 14A 0001140361-26-029955 filed 29 Jul 2026.
Roivant Sciences Ltd.'s CEO, Matthew Gline, earned $3,096,190 in total compensation for fiscal year 2025. Figures come from Roivant Sciences Ltd.'s DEF 14A 0001140361-26-029955 filed 29 Jul 2026.
Reading filings for ROIV...
Reading the latest proxy statement
Calculating CEO-to-worker ratio
Checking insider sales and trading plans